Adaptimmune Annual report pursuant to Section 13 and 15(d)

Accrued expenses and other current liabilities (Tables)

12 Months Ended

Dec. 31, 2020

Accrued expenses and other current liabilities consisted of the following (in thousands):


	December 31,		December 31,
	2020		2019
Accrued clinical and development expenditure	$	13,081	$	8,782
Accrued employee expenses		11,825		6,863
Other accrued expenditure		2,126		2,662
Accrued purchase commitments		—		5,000
Other		47		56
	$	27,079	$	23,363

The movements in the accrued purchase commitments are as follows (in thousands):


	Accrued purchase
	commitments
Accrued purchase commitments at January 1, 2019	$	—
Recognized in the year		5,000
Accrued purchase commitments at December 31, 2019 and January 1, 2020		5,000
Paid or invoiced during the year		(5,000)
Accrued purchase commitments at December 31, 2020	$	—